Skip to content

Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety

The Effect of Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety for Patients Undergoing First Eye Cataract Surgery

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00928772
Enrollment
115
Registered
2009-06-26
Start date
2009-07-31
Completion date
2012-02-29
Last updated
2017-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Keywords

Cranial Electro Stimulation, First Eye Cataract Surgery, Preoperative sedation, Perioperative sedation

Brief summary

Cranial electro stimulation (CES) provides safe, adequate, side-effect free sedation without excessive drowsiness in preoperative settings.

Detailed description

CES Alpha-Stim is a non-invasive device which has been in place and has been approved for patients to reduce anxiety by the FDA. This study involves the use of CES Alpha-Stim device applied to the patient 30 minutes before and through-out cataract surgery procedure and then to measure the level of anxiety and discomfort by using a visual analog scale (VAS). We propose that by applying the device the patients will be able to have markedly less level of anxiety and discomfort before and during the surgery and will ultimately avoid the traditional use of sedative or analgesic drugs being used for these kinds of surgery.

Interventions

DEVICECRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM

APPLYING OF ELECTRODES ON THE EAR LOBES AND TEMPLES WHICH ARE SENDING AN ACTIVE MICROCURRENT THROUGH THE MIDBRAIN PRODUCING SEDATION WITHOUT PHARMACOLOGICAL AGENTS AND GIVING NORMAL SALINE AS A SHAM DRUG SEDATION

DRUGMIDAZOLAM + SHAM ELECTRODES SIMULATING CRANIAL ELECTROTHERAPY

CONVENTIONAL METHOD OF PERIOPERATIVE SEDATION

OTHERNO SEDATION WITH SHAM CRANIAL ELECTROSTIMULATION AND PLACEBO VERSED

NO ACTIVE SEDATION, ONLY SHAM ELECTRODES AND NORMAL SALINE SIMULATING MIDAZOLAM.

Sponsors

University of Oklahoma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients of both genders between 50 and 90 years old scheduled for an outpatient first eye cataract phacoemulsification with topical anesthesia. * ASA classification I II and III

Exclusion criteria

* ASA classification IV (patients with a chronic or severe disease). * Hypersensitivity to midazolam or benzodiazepines * acute narrow-angle glaucoma * untreated open-angle glaucoma * Patients with any sort of psychiatric or neurological disorder * Patients on anti-anxiety medication * Patients who have demand-type pacemakers installed before 1999\* \*Note: These are the exclusions listed for liability purposes by Alpha-Stim. There are no FDA exclusions.

Design outcomes

Primary

MeasureTime frameDescription
Anxiety During Cataract Surgery Under Topical Anesthesiaduring the cataract surgery up to30 minutesAnxiety was accessed via VAS from 0 to 10 with 10 being the most anxious.

Secondary

MeasureTime frameDescription
Eye Discomfort Perception During Cataract Surgery Under Topical Anesthesiaduring cataract surgery up to 30 minutesVAS from 0 to 10 with 10 being maximal discomfort percieved
Mean Arterial Pressure During the Cataract Surgery Under Topical Anesthesiaduring cataract surgery up to 30 minutes
Heart Rate During Cataract Surgery Under Topical Anesthesiaduring cataract surgery up to 30 minutes

Countries

United States

Participant flow

Participants by arm

ArmCount
Alpha-Stim Intervention
One hour Alpha-Stim intervention with sham midazolam CRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM: APPLYING OF ELECTRODES ON THE EAR LOBES AND TEMPLES WHICH ARE SENDING AN ACTIVE MICROCURRENT THROUGH THE MIDBRAIN PRODUCING SEDATION WITHOUT PHARMACOLOGICAL AGENTS AND GIVING NORMAL SALINE AS A SHAM DRUG SEDATION
39
Sham Alpha-Stim With Midazolam
Sham Alpha-Stim intervention with real midazolam administration MIDAZOLAM + SHAM ELECTRODES SIMULATING CRANIAL ELECTROTHERAPY: CONVENTIONAL METHOD OF PERIOPERATIVE SEDATION
38
Placebo
No Alpha-Stim and only topical anesthetics NO SEDATION WITH SHAM CRANIAL ELECTROSTIMULATION AND PLACEBO VERSED: NO ACTIVE SEDATION, ONLY SHAM ELECTRODES AND NORMAL SALINE SIMULATING MIDAZOLAM.
38
Total115

Baseline characteristics

CharacteristicAlpha-Stim InterventionSham Alpha-Stim With MidazolamPlaceboTotal
Age, Customized
50-90 years
39 Participants38 Participants38 Participants115 Participants
Region of Enrollment
United States
39 Participants38 Participants38 Participants115 Participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants0 Participants
Sex: Female, Male
Male
39 Participants38 Participants38 Participants115 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 390 / 380 / 38
serious
Total, serious adverse events
0 / 390 / 380 / 38

Outcome results

Primary

Anxiety During Cataract Surgery Under Topical Anesthesia

Anxiety was accessed via VAS from 0 to 10 with 10 being the most anxious.

Time frame: during the cataract surgery up to30 minutes

ArmMeasureValue (MEAN)
Alpha-Stim InterventionAnxiety During Cataract Surgery Under Topical Anesthesia3.19 units on a scale
Sham Alpha-Stim With MidazolamAnxiety During Cataract Surgery Under Topical Anesthesia2.96 units on a scale
PlaceboAnxiety During Cataract Surgery Under Topical Anesthesia4.10 units on a scale
Secondary

Eye Discomfort Perception During Cataract Surgery Under Topical Anesthesia

VAS from 0 to 10 with 10 being maximal discomfort percieved

Time frame: during cataract surgery up to 30 minutes

ArmMeasureValue (MEAN)
Alpha-Stim InterventionEye Discomfort Perception During Cataract Surgery Under Topical Anesthesia2.58 units on a scale
Sham Alpha-Stim With MidazolamEye Discomfort Perception During Cataract Surgery Under Topical Anesthesia2.66 units on a scale
PlaceboEye Discomfort Perception During Cataract Surgery Under Topical Anesthesia2.79 units on a scale
Secondary

Heart Rate During Cataract Surgery Under Topical Anesthesia

Time frame: during cataract surgery up to 30 minutes

ArmMeasureValue (MEAN)
Alpha-Stim InterventionHeart Rate During Cataract Surgery Under Topical Anesthesia64.6 Beats per minute
Sham Alpha-Stim With MidazolamHeart Rate During Cataract Surgery Under Topical Anesthesia65.4 Beats per minute
PlaceboHeart Rate During Cataract Surgery Under Topical Anesthesia67.9 Beats per minute
Secondary

Mean Arterial Pressure During the Cataract Surgery Under Topical Anesthesia

Time frame: during cataract surgery up to 30 minutes

ArmMeasureValue (MEAN)
Alpha-Stim InterventionMean Arterial Pressure During the Cataract Surgery Under Topical Anesthesia99.5 mmHg
Sham Alpha-Stim With MidazolamMean Arterial Pressure During the Cataract Surgery Under Topical Anesthesia99.8 mmHg
PlaceboMean Arterial Pressure During the Cataract Surgery Under Topical Anesthesia104.5 mmHg

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026